Complete Genomics Drives Down Cost of Genome Sequence to $5,000
This article is for subscribers only.
Complete Genomics, which offers DNA analysis services to drugmakers and other companies, will begin in June to sequence human genomes for $5,000, a far cry from the $2.3 billion the first sequencing cost in 2003.
The service will be offered to drugmakers, biotechnology companies, and academic centers, said Clifford Reid, chairman and chief executive officer of the closely held Mountain View, California-based company, in a telephone interview. It won’t be available to individuals.